Improved survival in rheumatoid arthritis: A general population-based cohort study

Annals of the Rheumatic Diseases

Volumn 76, Issue 2, 2017, Pages 408-413

  Zhang, Yuqing ^a   Lu, Na ^a   Peloquin, Christine ^a   Dubreuil, Maureen ^a   Neogi, Tuhina ^a   Aviña Zubieta, J Antonio ^b   Rai, Sharan K ^c   Choi, Hyon K ^a,b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

DMARDs (biologic); Epidemiology; Rheumatoid Arthritis

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; POPULATION RESEARCH; RHEUMATOID ARTHRITIS; SURVIVAL; ARTHRITIS, RHEUMATOID; DRINKING BEHAVIOR; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; SMOKING; SURVIVAL RATE; TRENDS; UNITED KINGDOM;

ADULT; AGED; ALCOHOL DRINKING; ARTHRITIS, RHEUMATOID; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; SMOKING; SURVIVAL RATE; UNITED KINGDOM;

EID: 84978953992     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-209058     Document Type: Article

References (27)

1. Dadoun S, Zeboulon-Ktorza N, Combescure C, et al. Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint Bone Spine 2013;80:29-33.
2. O'Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004;350:2591-602.
3. Singh JA, Saag KG, Bridges SL, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2016;68:1-25.
4. Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014;73:492-509.
5. Ward MM. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Arthritis Rheum 2004;50:1122-31.
6. Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010;69:325-31.
7. Gonzalez A, Maradit Kremers H, Crowson CS, et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007;56:3583-7.
8. Humphreys JH, Warner A, Chipping J, et al. Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken) 2014;66:1296-301.
9. Saunders SA, Capell HA, Stirling A, et al. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum 2008;58:1310-17.
10. National Health Service (NHS). Read codes: NHS connecting for health. http://www. connectingforhealth.nhs.uk/systemsandservices/data/uktc/readcodes
11. First Databank. Multilex drug data file. http://www.firstdatabank.co.uk/8/multilexdrug- data-file
12. Blak BT, Thompson M, Dattani H, et al. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care 2011;19:251-5.
13. Rodríguez LA, Tolosa LB, Ruigómez A, et al. Rheumatoid arthritis in UK primary care: incidence and prior morbidity. Scand J Rheumatol 2009;38:173-7.
14. Watson DJ, Rhodes T, Cai B, et al. Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. Arch Intern Med 2002;162:1105-10.
15. Thomas SL, Edwards CJ, Smeeth L, et al. How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum 2008;59:1314-21.
16. Khan NF, Perera R, Harper S, et al. Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract 2010;11:1.
17. Rod NH, Lange T, Andersen I, et al. Additive interaction in survival analysis: use of the additive hazards model. Epidemiology 2012;23:733-7.
18. Raghunathan TE, Lepkowski JM, Van Hoewyk J, et al. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol 2001;27:85-95.
19. Lash TL, Fox MP, Fink AK. Applying quantitative bias analysis to epidemiologic data. New York: Springer, 2009.
20. Harty L, O'Toole G, FitzGerald O. Profound reduction in hospital admissions and musculoskeletal surgical procedures for rheumatoid arthritis with concurrent changes in clinical practice (1995-2010). Rheumatology (Oxford) 2015;54:666-71.
21. Choi HK, Nguyen US, Niu J, et al. Selection bias in rheumatic disease research. Nat Rev Rheumatol 2014;10:403-12.
22. García Rodríguez LA, Varas-Lorenzo C, Maguire A, et al. Nonsteroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. Circulation 2004;109:3000-6.
23. Martín-Merino E, García-Rodríguez LA, Massó-González EL, et al. Do oral antimuscarinic drugs carry an increased risk of acute urinary retention? J Urol 2009;182:1442-8.
24. Hall GC. Validation of death and suicide recording on the THIN UK primary care database. Pharmacoepidemiol Drug Saf 2009;18:120-31.
25. Meal A, Leonardi-Bee J, Smith C, et al. Validation of THIN data for non-melanoma skin cancer. Qual Prim Care 2008;16:49-52.
26. Martín-Merino E, Ruigómez A, Johansson S, et al. Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns. Prim Care Companion J Clin Psychiatry 2010;12:PCC 08m00764.
27. Prasad V. But how many people died? Health outcomes in perspective. Cleve Clin J Med 2015;82:146-50.